Ⅰ型变态反应生物学治疗的研究进展
Recent development in the biologic therapy of type Ⅰ allergic disease
摘要
Ⅰ型变态反应生物学治疗已得到全世界的广泛关注,其研究近期也有了长足进展。现主要从特异性和非特异性治疗两大方面就其发展进行总结、归纳,对Ⅰ型变态反应病的临床治疗有一定的参考价值。
出处
《国外医学（临床生物化学与检验学分册）》
2005年第12期901-903,共3页
Foreign Medical Sciences(section of Clinical Biochemistry and Laboratory Medicine
基金
国家自然科学基金资助项目(30171200)
参考文献14
-
1Valenta R. The future of antigen-specific immunotherapy of allergy. Nat Rev Immunol, 2002, 2(6): 446-453.
-
2Flicker S, Vrtala S, Steinberger P, et al. A human monoclonal IgE antibody defines a highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5: molecular, immunological, and structural characterization of the epitope-containing domain. J Immunol, 2000, 165 ( 7 ) :3849-3859.
-
3Swoboda I, De-Weerd N, Bhalla PL, et al. Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE-binding capacity: candidates for grass pollen-specific immunotherapy. Eur J Immunol, 2002, 32 (1) : 270-280.
-
4Roy K, Mao HQ, Huang SK, et al. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med,1999, 5(4): 387-391.
-
5Kline JN, Kitagaki K, Businga TR, et al. Treatment of established asthma in a murine model using CpG oligodeoxynucleotides. Am J Physiol Lung Cell Mol Physiol,2002, 283(1); L170- L179.
-
6Slater JE, Paupore E, Zhang YT, et al. The latex allergen Hey b 5 transcript is widely distributed after subcutaneous injection in BALB/c mice of its DNA vaccine. J Allergy Clin Immunol, 1998, 102(3): 469-475.
-
7Ali FR, Oldfield WL, Higashi N, et al. Late asthmatic reactions induced by inhalation of allergen-derived T cell peptides. Am J Respir Crit Care Med, 2004, 169(1): 20-26.
-
8Kricek F, Ruf C, Rudolf MP, et al. IgE-related peptide mimotopes. Basic structures for anti-allergy vaccine development. Int Arch Allergy Immunol, 1999, 118(2-4): 222-223.
-
9Casale TB, Bernstein IL, Busse WW, et al. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol, 1997, 100 (1):110-121.
-
10Leung DY, Sampson HA, Yunginger JW, et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med, 2003, 348(11): 986-993.
-
1蔡后荣.间质性肺疾病的临床治疗进展[J].临床内科杂志,2005,22(4):223-226. 被引量：11
-
2孙天国,蒋玉红.β受体阻滞剂在心力衰竭生物学治疗中的应用[J].航空航天医药,2001,12(3):168-169.
-
3戴闺柱.心力衰竭生物学治疗的新认识[J].中华心血管病杂志,2000,28(4):314-316. 被引量：146
-
4赵林凤,赵琦.美托洛尔与依那普利联用治疗慢性充血性心力衰竭疗效观察[J].中国心血管病研究,2004,2(11):902-903. 被引量：4
-
5王卉,钟永云.生物学治疗在心力衰竭临床中的应用[J].中国药业,2002,11(12):66-67.
-
6尚怀玉.慢性充血性心力衰竭生物学治疗62例临床观察[J].现代医药卫生,2003,19(2):157-158.
-
7周惠琼,吴东海.类风湿关节炎的生物学治疗[J].风湿病学杂志,1997,2(4):49-52.
-
8朱琼祥,曾广强.慢性阻塞性肺疾病伴脑卒中105例分析[J].内科,2007,2(1):37-39. 被引量：4
-
9许嘉宏,赵明中.慢性心力衰竭的非药物治疗[J].中国社区医师,2006,22(13):12-13.
-
10陈屹,曹优文.曲美他嗪治疗慢性心力衰竭40例临床观察[J].现代医药卫生,2010,26(18):2798-2799.
